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ABSTRACT
Background and study aims Uptake of flexible sigmoidoscopy
screening in the English Bowel Scope Screening (BSS) Programme
is low. The aim of this study was to test the impact of a nonpartici-
pant reminder and theory-based leaflet to promote uptake among
former nonresponders (previously did not confirm their appoint-
ment) and nonattenders (previously confirmed their appointment
but did not attend).
Patients and methods Eligible adults were men and women in Lon-
don who had not attended a BSS appointment within 12 months of
their invitation. Individuals were randomized (1:1:1) to receive no
reminder (control), a 12-month reminder plus standard information
booklet (TMR-SIB), or a 12-month reminder plus bespoke theory-
based leaflet (TMR-TBL) designed to address barriers to screening.
The primary outcome of the study was the proportion of individuals
screened within each group 12 weeks after the delivery of the re-
minder.
Results A total of 1383 men and women were randomized and an-
alyzed as allocated (n =461 per trial arm). Uptake was 0.2% (n =1),
10.4% (n =48), and 15.2% (n=70) in the control, TMR-SIB, and TMR-
TBL groups, respectively. Individuals in the TMR-SIB and TMR-TBL
groups were significantly more likely to attend screening than indi-
viduals in the control group (adjusted odds ratio [OR] 53.7, 95%
confidence interval [CI] 7.4–391.4, P<0.001 and OR 89.0, 95%CIs
12.3–645.4, P <0.01, respectively). Individuals in the TMR-TBL
group were also significantly more likely to attend screening than
individuals in the TMR-SIB group (OR 1.7, 95%CIs 1.1–2.5, P=
0.01). Across all groups, former nonattenders were more likely to
participate in screening than former nonresponders (uptake was
14.2% and 8.0%, respectively; OR 2.5, 95%CIs 1.4–4.4, P <0.01).
The adenoma detection rate among screened adults was 7.6%,
which is comparable to the rate in initial attenders.
Conclusions Reminders targeting former nonparticipants can im-
prove uptake and are effective for both former nonresponders and
nonattenders. Theory-based information designed to target barri-
ers to screening added significantly to this strategy.
Original article
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Introduction
In March 2013, NHS England extended its national Bowel Can-
cer Screening Programme to include once-only flexible sigmoi-
doscopy screening for men and women aged 55 years [1]. The
decision to extend the program and include flexible sigmoido-
scopy was made in response to the results of a large UK ran-
domized controlled trial (RCT), which demonstrated that a
one-off screen between the ages of 55 and 64 years significant-
ly reduced the incidence and mortality of colorectal cancer
(CRC) among screened adults [2].
Uptake of the test (also referred to as bowel scope screening
[BSS]) in England is currently very low (only 43% of invitees at-
tend an appointment) [3], which will ultimately undermine the
clinical effectiveness of the program [4]. Data on uptake in
other countries are sparse, but it has been documented to be
as low as 29% in regions of Italy [5] and as high as 63% in the
Norwegian Colorectal Cancer Prevention Trial [6].
Detailed surveys issued to nonparticipants and their health-
care providers have identified the most prevalent patient-relat-
ed factors for not attending a flexible sigmoidoscopy appoint-
ment as: a lack of current health problems, practical barriers
(i. e. inconvenient appointment time/day), worry about pain,
discomfort, or injury associated with the examination, and not
wanting to know about any health issues [7–9]. Subsequent
studies have suggested that interventions which address pa-
tient-specific barriers to the test might improve uptake [10,
11]; however, the evidence to support the use of such strate-
gies is inconsistent [12–18].
Organizational changes, such as those affecting the mecha-
nisms for scheduling appointments, self-referral, and patient
outreach have been more effective at increasing patient parti-
cipation [19–23]. Pre-notification letters, timed appoint-
ments, and pre-appointment reminders have all been shown
to improve uptake of flexible sigmoidoscopy screening and, as
with other screening, these specific strategies have been incor-
porated into the BSS pathway [5, 24–26]. Repeat invitations
have additionally been shown to improve uptake of CRC screen-
ing tests (such as the fecal occult blood test and colonoscopy)
by providing additional opportunities for people to take part
[27–29]. In Italy, Senore et al. made similar observations in
the context of a flexible sigmoidoscopy-based program when
they sent former nonresponders a reminder letter 3 months
after the invitation, yielding a 4.5% absolute increase in uptake
[5].
In the BSS program, invitees who do not attend screening at
the age of 55 years can self-refer for the test up until the age of
60, but do not receive a formal reminder of this opportunity. A
recent single-arm feasibility study examining the format of a
12-month reminder for a center in London found that, when
sent with a bespoke cover letter and information leaflet, the re-
minder facilitated uptake in 15.5% of former nonresponders
[30]. Although highly promising, these current studies of non-
responder reminders are limited to observational data from sin-
gle-arm trials [5, 30]. The effectiveness of these interventions
and some of their key components therefore still require formal
evaluation in multi-arm RCTs. One such component requiring
further investigation is the bespoke, theory-based leaflet used
in the feasibility study [30], which had been designed to ad-
dress several barriers to screening by providing bespoke infor-
mation on how to get to the screening center and by including
testimonials from locally screened adults [30]. Using local tai-
loring for the whole program would incur additional financial
and logistical costs, which would need to be justified.
Another hitherto untested component of these reminders is
their differential impact on specific groups of nonparticipants,
as to date current studies have focused exclusively on former
nonresponders (i. e. individuals who previously did not confirm
nor attend their appointment) [5, 30]. Previous research has
shown that individuals who confirm an appointment, but then
do not attend (i. e. former nonattenders), are both demogra-
phically and qualitatively different from their screened and
nonresponding counterparts [31], with previously screened
adults having “better subjective health” and “lower levels of de-
privation” and former nonresponders having “lower levels of
perceived benefits and anticipated regret” and higher levels of
“cancer fear and fatalism” [31]. As it stands, there is no pub-
lished information about the prevalence of this important sub-
group of nonparticipants in the English BSS program or how
they would respond to interventions inviting them to re-en-
gage with the program.
The present study therefore set out to extend the evaluation
of nonparticipant reminders to increase uptake of flexible sig-
moidoscopy screening by: 1) comparing uptake between indi-
viduals receiving a reminder compared with usual care (i. e. no
reminder) in an RCT; 2) subdividing nonparticipants into former
nonattenders and former nonresponders; and 3) testing the ad-
ded benefit of including a bespoke theory-based leaflet with
the reminder.
Patients and methods
Study design and trial setting
We performed a single-blind RCT with three parallel arms in the
London Boroughs of Brent and Harrow. Researchers were blind-
ed to the treatment that subjects received until all data had
been collected at the end of the study. Because individuals
were given a reminder plus the standard information booklet,
no reminder, or a reminder plus the locally tailored theory-
based leaflet, it was not possible to blind them to the treatment
they received. In terms of the study setting, the London Bor-
oughs of Brent and Harrow have below-average uptake (40%
vs. 43%, respectively), and individuals living in these boroughs
predominantly live in the most ethnically diverse and socioeco-
nomically deprived areas of England [4].
Study population
Eligible adults were men and women registered with a general
practice in the London Boroughs of Brent and Harrow. Adults
registered with these practices were eligible for inclusion in
the study if they had not attended a BSS appointment within
12 months of receiving their invitation. Eligible adults included
both those who previously did not respond to the initial invita-
tion at the age of 55 years (former nonresponders) as well as
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those who confirmed an appointment but did not attend (for-
mer nonattenders).
Procedures
Eligible adults were identified from the NHS Bowel Cancer
Screening System (BCSS) [32]. To ensure workforce capacity
(i. e. that all self-referred appointments could be facilitated
without disruption to routine appointments), eligible adults
were enrolled over a 20-week period spanning February to Au-
gust 2015.On the basis that there was capacity to facilitate an
additional five appointments per week, and that 5% of individ-
uals across the three groups would make and attend an ap-
pointment each week, we conservatively selected 69 adults for
inclusion in the study each week (from a variable weekly total)
using simple pseudo-random selection methods [33] (▶Fig. 1).
Individuals selected for inclusion in the study were then ran-
domly assigned using simple pseudorandom allocation meth-
ods (in a 1:1:1 ratio) to receive: no reminder (control); a mailed
12-month reminder plus a standard information booklet (TMR-
SIB); or a mailed 12-month reminder plus a locally tailored the-
ory-based leaflet (TMR-TBL) designed to address barriers to
screening.
Individuals allocated to the control group were provided
with usual care and therefore did not receive a reminder. Indi-
viduals allocated to the reminder groups were sent a reminder
letter with one of two leaflets, an appointment-request slip,
and a freepost return envelope addressed to St Mark’s Bowel
Cancer Screening Centre (▶Fig. 1).
Individuals in both reminder groups were able to book an ap-
pointment by returning their appointment-request slip in the
freepost envelope provided, thereby initiating a call from a
member of the administrative team to arrange an appoint-
ment, or by calling the screening center directly on the Free-
phone telephone number highlighted in the reminder letter.
Individuals not responding to the reminder within 4 weeks
were sent a follow-up reminder (▶Fig. 1), which also included
an appointment-request slip, the allocated information leaflet,
and a freepost return envelope. Individuals were then given 8
more weeks to respond, after which they were not included in
the study results. Individuals who self-referred for the test also
received a pre-appointment text-message reminder and tele-
phone call, as per routine appointments at St Mark’s Hospital.
The study was approved by the North East–Tyne & Wear
South Research Ethics Service (Ref: 15 /NE/0043) and was regis-
tered with the International Standard Randomised Controlled
Trials Number Registry for transparency (trial ID:
ISRCTN44293755).
Intervention details
Full descriptions of the intervention materials and their devel-
opment are available in the feasibility study [30].
12-month reminder
The 12-month reminder was a personally addressed letter from
St Mark’s Hospital that invited recipients to make a new ap-
pointment by returning an appointment-request slip or by call-
ing the Freephone telephone number for the screening center
(▶Appendix e1, available online). The reminder also gave reci-
pients the option to express a preference for the day and time
1503 non-participants identified via BCSS
1383 randomly selected for inclusion in the study
461 randomly allocated to Control (1) 461 randomly allocated to TMR-SIB (2) 461 randomly allocated to TMR-TBL (3)
Attendance at screening Attendance at screening Attendance at screening
Analyzed as allocated Analyzed as allocated Analyzed as allocated
No reminder letter 
(treatment as usual care)
461 sent 12-month reminder 
+ standard information booklet
461 sent 12-month reminder 
+ theory-based leaflet
No reminder letter 
(treatment as usual care)
0 referred for 
screening
37 referred for 
screening
48 referred for 
screening
8 returned to 
sender
20 returned to 
sender
416 sent follow-up reminder  
+ standard information booklet
393 sent follow-up reminder 
+ theory-based leaflet
Enrollment
Allocation
Intervention
Outcome
Analysis
▶ Fig. 1 Trial flowchart/CONSORT diagram. BCSS, Bowel Cancer Screening System; TMR, 12-month reminder; SIB, standard information
booklet; TBL, theory-based leaflet.
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of the appointment, as well as the sex of the practitioner per-
forming the test.
Theory-based leaflet (TMR-TBL)
The theory-based leaflet was a locally tailored leaflet co-de-
signed by Resonant, a social marketing company specializing
in health behavior (see ▶Appendix e2, available online). The
development of the leaflet was based on two psychological
models of behavior previously used to explain factors associat-
ed with uptake [34]: the Health Belief Model [35] and Social
Cognitive Theory [36]. To address barriers to participation, the
leaflet included an educational/knowledge-building compo-
nent and several practical components designed to improve
self-efficacy (including local transport information and direc-
tions to the hospital).
Standard information booklet
The standard information booklet was the same 16-page book-
let that was previously sent with the initial invitation as part of
the national program (available from: https://www.gov.uk/gov-
ernment/uploads/system/uploads/attachment_data/file/
423928 /bowel-scope-screening.pdf). The standard informa-
tion booklet was developed by King’s Health Partners who de-
veloped the booklet in accordance with principles put forth by
NHS England’s informed choice initiative [37].
Follow-up reminder
The follow-up reminder was a personally addressed letter from
St Mark’s Hospital that reiterated the opportunity to self-refer
for screening up until the age of 60 years (▶Appendix e3, avail-
able online).
Measures
Routinely available data on the BCSS were used to verify self-re-
ferral and attendance 4 and 12 weeks following the distribution
of the 12-month reminder letter. The BCSS was also consulted
to obtain the sex, area (i. e. Brent or Harrow), and initial episode
status (i. e. former nonresponder or former nonattender) of
each person included in the trial. For those who attended an ap-
pointment, the BCSS was additionally consulted to obtain the
proportion of people screened who had one or more adenomas
detected.
An area-based socioeconomic deprivation score was gener-
ated for each person by converting individual postcodes into a
score on the 2010 Index of Multiple Deprivation (IMD) [38].
Area-level IMD scores were then categorized into tertiles of
their regional distributions to enable comparisons between
the most and least deprived areas.
Statistics
Sample size
The sample size (n =1383) was calculated using a standard test
of difference between two proportions. As the study included
three trial arms (one receiving usual care and two receiving a
reminder with one of two leaflets), the calculation was repeat-
ed for each pairwise comparison comprising a primary research
question in the planned analysis. The final calculation gave a to-
tal sample size requirement of 461 people per trial arm to test
for a 5% difference in uptake between any two of the three
groups, with expected values of 0%, 5%, and 10% for the con-
trol, TMR-SIB, and TMR-TBL groups respectively. The study was
designed to detect differences at the two-sided 5% alpha level
with a 20% margin for type II error.
Data analysis
Univariate logistic regression was used to investigate the asso-
ciations between treatment groups and self-referral and up-
take. To counteract the problem of multiple comparisons, we
used the Bonferroni correction method, comparing outcomes
to an adjusted significance level of 0.015. Adjusted odds ratios
(ORs) and 95% confidence intervals (CIs) were calculated using
multivariate logistic regression after adjusting for baseline
characteristics. To explore possible associations between not
attending a confirmed appointment and previous episode sta-
tus (i. e. former nonattender, former nonresponder), we carried
out a subgroup analysis using univariate and multivariate logis-
tic regression.
The adenoma detection rate (ADR) was reported using de-
scriptive statistics; the data were analyzed on an intention-to-
treat basis using SPSS software (version 22; IBM Corp., Armonk,
New York, USA).
Results
Sample characteristics
The study took place between February and August 2015, with
follow-up until October 2015.A total of 1383 adults were ran-
domized and analyzed as allocated. The majority of individuals
were registered with a general practice in the London Borough
of Brent (n=928; 67.1%), did not respond to the initial invita-
tion (n =1255, 90.7%), and were female (n =727; 52.6%) (▶Ta-
ble1).
Uptake of bowel scope screening
In total, 119 people (8.6%) attended an appointment across all
three study groups (▶Table 2). A further 41 (3.0%) made an ap-
pointment, but then either did not attend (n =21) or cancelled
(n =20), leaving 1223 (88.4%) adult men and women who nei-
ther made nor attended an appointment (▶Table 2).
There was strong evidence of differences in booked and at-
tended appointments between the reminder groups and the
control (▶Table2). A total of 48 individuals (10.4%) in the
TMR-SIB group and 70 (15.2%) in the TMR-TBL group attended
an appointment (▶Table 2) compared with only 1 (0.2%) in the
control group (OR 53.5, 95%CIs 7.4–389.1, P<0.001; OR 82.4,
95%CIs 11.4–595.6, P <0.001 for the TMR-SIB and TMR-TBL
groups, respectively). There was also a strong trend toward dif-
ferences in uptake between the reminder groups, with individ-
uals in the TMR-TBL group being more likely to attend an ap-
pointment than individuals in the TMR-SIB group (OR 1.5, 95%
CI 1.0–2.3, P=0.03).
Results were similar after adjusting for baseline characteris-
tics in the multivariate analysis (▶Table2), with strong evi-
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dence of significant differences between the reminder groups
and control (TMR-SIB vs. control: OR 53.7, 95%CIs 7.4–391.4,
P<0.001; TMR-TBL vs. control: OR 89.0, 95%CIs 12.3–645.4, P
<0.001). After adjusting for baseline characteristics, there was
also strong evidence for a difference in participation between
intervention groups, with individuals in the TMR-TBL group
being more likely to book and attend an appointment than in-
dividuals in the TMR-SIB group (OR 1.7, 95%CIs 1.1–2.5; P=
0.01). There was also strong evidence of a difference in uptake
by initial episode status after adjusting for study group and
other baseline characteristics (▶Table 3), with former nonat-
tenders being nearly twice as likely to book and attend an ap-
pointment than former nonresponders (14.2% and 8.0%,
respectively; OR 2.5, 95%CI 1.4–4.4; P<0.01). There was no
evidence of an association between screening uptake and sex,
regional IMD tertile, or area (all P values > 0.05; ▶Table 3).
Confirmed appointments
A total of 41 individuals booked an appointment but did not at-
tend.Attendanceof a confirmedappointmentwashigher among
former nonattenders than former nonresponders (81.8% vs.
73.0%); however, the results of the regression revealed that
▶Table 1 Description of the trial population.
Control
(n =461)
TMR-SIB
(n=461)
TMR-TBL
(n=461)
Total
(n=1383)
Sex, n (%)
Female 261 (56.6) 238 (51.6) 228 (49.5)  727 (52.6)
Male 200 (43.4) 223 (48.4) 233 (50.5)  656 (47.4)
Area, n (%)
Brent 304 (65.9) 302 (65.5) 322 (69.8)  928 (67.1)
Harrow 157 (34.1) 159 (34.5) 139 (30.2)  455 (32.9)
Tertile of deprivation (IMD score), n (%)
Tertile 1 (0.00–17.68) 152 (33.0) 144 (31.2) 133 (28.9)  429 (31.0)
Tertile 2 (17.69–27.50) 164 (35.5) 162 (35.0) 179 (38.8)  505 (36.5)
Tertile 3 (27.51–80) 140 (30.4) 151 (32.8) 144 (31.2)  435 (31.5)
Missing   5 (1.1)   4 (0.9)   5 (1.1)   14 (1.0)
Initial episode status, n (%)
Nonresponder 411 (89.2) 408 (88.5) 436 (94.6) 1255 (90.7)
Nonattender  50 (10.8)  53 (11.5)  25 (6.4)  128 (9.3)
TMR, 12-month reminder; SIB, standard information booklet; TBL, theory-based leaflet; IMD, Index of Multiple Deprivation.
▶Table 2 Self-referral and uptake by trial arm (univariate and multivariate regression outcomes).
Mean, n (%) Unadjusted OR (95%CI) Adjusted OR (95%CI)1
Made an appointment (n =160)
Control vs. TMR-SIB 1 vs. 64 (0.2 vs. 13.9) 74.16 (10.24–536.97) 2 73.27 (10.11–531.11) 2
Control vs. TMR-TBL 1 vs. 95 (0.2 vs. 20.6) 119.40 (16.57–860.49) 2 130.36 (18.05 –941.54) 2
TMR-SIB vs. TMR-TBL 64 vs. 95 (13.9 vs. 20.6) 1.61 (1.14–2.28) 3 1.78 (1.25 –2.54) 3
Attended an appointment (n =119)
Control vs. TMR-SIB 1 vs. 48 (0.2 vs. 10.4) 53.46 (7.35– 389.05) 2 53.73 (7.38–391.39) 2
Control vs. TMR-TBL 1 vs. 70 (0.2 vs. 15.2) 82.35 (11.39–595.58) 2 89.01 (12.28–645.40) 2
TMR-SIB vs. TMR-TBL 48 vs. 70 (10.4 vs. 15.2) 1.54 (1.04–2.28)4 1.69 (1.13 –2.52) 3
OR, odds ratio; CI, confidence interval. n = 461 for all groups, respectively.
1 Adjusted ORs and 95%CIs are adjusted for sex, area, deprivation, and initial episode status.
2 P≤0.001
3 P≤0.01
4 P≤0.05
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there was no significant difference between these two groups
(OR 1.4, 95%CIs 0.4–4.6) (▶Appendix e4). A significant differ-
ence in attendance was observed between men and women
(80.5% vs. 68.3%), with men being more likely to attend than
their female counterparts (OR 2.2, 95%CI 1.0–4.7). There
were no significant differences in the nonattendance rate for
any of the other covariates included in the analysis (all P values
> 0.05).
Adenoma detection rate
Of the 119 individuals who attended an appointment and were
screened, 9 (7.6%) had one or more adenomas detected, 6 of
whom also met the clinical criteria for colonoscopy and subse-
quently underwent further examination. No patient was diag-
nosed with cancer.
Discussion
This trial was initiated to test the impact of a 12-month remin-
der compared with usual care in an RCT. It is the first study to
subdivide nonparticipants in order to test the effect of long-
term reminders on former nonresponders and former nonat-
tenders independently. This study also examined the added
benefit of including a bespoke, theory-based leaflet with the re-
minder by including a third parallel arm to the trial design.
The results of this RCT provide strong evidence to support
the use of a 12-month reminder in the national BSS program
and highlight an additional benefit of including a bespoke, the-
ory-based leaflet among a group of adults who have previously
received the full suite of information as part of the initial invita-
tion (uptake was 0.2%, 10.4% and 15.2% in the control, TMR-
SIB, and TMR-TBL groups, respectively).
At the current rate of attendance (43%) [3], inclusion of a
12-month reminder in the national BSS program would increase
uptake by approximately 6–9 percentage points (estimated by
multiplying the proportion of adults not attending an initial ap-
pointment [0.57] by the proportion of adults attending in re-
sponse to the 12-month reminder either with the SIB [0.10] or
the TBL [0.15]), depending on which of the two leaflets were
adopted. As uptake was consistent between men and women,
as well as between tertiles of socioeconomic deprivation, it is
unlikely that implementing a 12-month reminder with either
leaflet would exacerbate existing inequalities in participation
[3].
It is interesting to note that while uptake did not vary by sex,
area, or area-level deprivation, it did vary by previous episode
status, with former nonattenders being more likely to book
▶Table 3 Self-referral and uptake by baseline characteristics (univariate and multivariate regression outcomes).
Made an ap-
pointment,
n (%)
Unadjusted
OR
(95%CI)
Adjusted OR
(95%CI)1
Attended an
appointment,
n (%)
Unadjusted
OR
(95%CI)
Adjusted OR
(95%CI)1
Sex
Women2 (n =727)  83 (11.4) – –  57 (7.8) – –
Men (n=656)  77 (11.7) 1.03
(0.74 –1.44)
0.94
(0.67–1.33)
 62 (9.5) 1.23
(0.84–1.79)
1.18
(0.80–1.75)
Area
Brent2 (n = 926) 101 (10.9) – –  75 (8.1) – –
Harrow (n =457)  59 (12.9) 1.21
(0.86 –1.71)
1.39
(0.89–2.18)
 44 (9.6) 1.21
(0.82–1.79)
1.34
(0.80–2.22)
Deprivation
Tertile 12 (n = 429)  49 (11.4) – –  38 (8.9) – –
Tertile 2 (n = 505)  59 (11.7) 1.03
(0.69 –1.54)
1.20
(0.74–1.95)
 41 (8.1) 0.91
(0.57–1.44)
1.05
(0.61–1.81)
Tertile 3 (n = 435)  51 (11.7) 1.03
(0.68 –1.56)
1.29
(0.76–2.21)
 40 (9.2) 1.04
(0.65–1.66)
1.28
(0.71–2.33)
Initial episode status
Nonresponder2 (n = 1256) 138 (11.0) – – 101 (8.0) – –
Nonattender (n = 127)  22 (17.3) 1.704
(1.04 –2.78)
2.243
(1.30–3.85)
 18 (14.2) 1.894
(1.10–3.24)
2.453
(1.36–4.40)
OR, odds ratio; CI, confidence interval.
1 Adjusted ORs and 95%CIs are adjusted for trial arm and all other covariates in the table.
2 Reference category.
3 P≤0.01
4 P≤0.05
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and attend an appointment than former nonresponders (14.2%
vs. 8.0%). One possible explanation for this difference is that
former nonattenders, who perceive fewer barriers and more
benefits to screening than nonresponders, are qualitatively
similar to screened adults, but have difficulty translating their
intentions into actions due to circumstantial aspects, such as
poor health [31]. Previous research by Ferrer et al. has shown
that participation in CRC screening is a behavioral process com-
prising several qualitatively distinct stages through which indi-
viduals move based on their readiness to be screened [39]. Each
stage is strongly associated with a specific set of attitudes and
beliefs toward the test, and it may be that the interventions
used in our study were more effective at facilitating forward-
stage transitions in former nonattenders by addressing issues
that are specific to those who have already engaged with the
program by making an appointment. It is also possible that it
may simply be easier to facilitate forward-stage transitions in
individuals who have previously responded to the initial invita-
tion than in individuals who have not, and so the higher re-
sponse in former nonattenders may have been observed for
this reason. It is also important to note that, contrary to pre-
vious studies suggesting that nonattenders might never trans-
late their intentions into actions [30], we found that the atten-
dance rate for those confirming an appointment was actually
higher (although not significantly higher) among former nonat-
tenders than former nonresponders (81.2% and 73.0%, respec-
tively).
Although this particular subgroup of nonparticipants does
not comprise a substantial proportion of the population (we
find that they only account for approximately 10% of individ-
uals), they do represent a willing group who respond well to
these interventions and as such should not be excluded.
We also found that women who made an appointment were
less likely to attend screening than men who made an appoint-
ment (68.3% vs. 80.5%), and this was consistent with previous
research examining factors associated with non-attendance
[31]. One possible explanation as to why women were less likely
to attend a screening appointment than men who made an ap-
pointment is that women perceive more barriers to (flexible
sigmoidoscopy) screening [40], which make it more difficult
for them to attend [8].
It is possible that a telephonic reminder would have been
more effective [19–21]. However, telephonic reminders are
not considered cost-effective for CRC screening and as such
are not recommended by the European Quality Assurance
Guidelines for Colorectal Cancer Screening [41]. In addition,
the screening center does not have access to patient telephone
numbers (unless patients have provided a number, in which
case they are available for responders and a telephone remin-
der for the appointment is given). Given this and the results of
the present study, we would advocate the adoption of a 12-
month mailed reminder for nonparticipants by the national
program prior to full population coverage in 2018. From a clin-
ical perspective, this intervention can be considered worth-
while, given that the ADR reported in our study (7.6%) is com-
parable to the rate associated with the initial invitation (9.8%)
[24].
There has been little positive research concerning the im-
pact of theory-based materials on CRC screening rates [12–
18], particularly with regard to flexible sigmoidoscopy screen-
ing [21]. The finding that the bespoke, theory-based leaflet
used in this study was effective is therefore highly promising.
Not only does it demonstrate that such materials can be effec-
tive, but also that they can be implemented in ways that do not
contravene General Medical Council guidelines for informed
consent. It is possible that this type of leaflet might also be ef-
fective at other stages of the invitation pathway (for instance, if
sent with the pre-notification or pre-appointment reminder let-
ters), although it may be that it worked well because it was sent
to a group of individuals for whom the standard information
was not suitable.
Our study has several limitations. First, we only tested the
impact of a 12-month reminder at one screening center and
cannot say whether the interventions described here would be
as effective outside of the study setting. Furthermore, to en-
sure endoscopy capacity (i. e. that all appointments could be fa-
cilitated), we selected only a proportion of former nonpartici-
pants for this trial and not the entire eligible population. At
this point it would be important to investigate the feasibility of
rolling out these reminders across the entire eligible popula-
tion, as well as at other centers. Other factors, such as recent
bowel symptoms [8], which are associated with uptake of BSS,
could not be examined because our study was embedded
within the program, which does not have access to this infor-
mation. As such, it was not possible to obtain the frequency of
people coming forward in response to the reminder for this rea-
son. It would be informative to know whether those coming for
the test in response to the reminder had experienced a recent
bowel symptom and whether this played a role in their motiva-
tion for making an appointment when previously they had not
attended. These individuals may be more likely to have bowel
disease and thereby benefit from the test. Future studies using
questionnaires alongside these reminders might be able to pro-
vide more information on this issue. Finally, as the reminder
used in this study consisted of multiple components, including
a choice of practitioner and options for the time and day of the
appointment, it is not clear how much each component con-
tributed to uptake. It would be prudent to evaluate each com-
ponent independently and to investigate whether additional
components, such as general practice endorsement, having
the enema administered at the hospital, and offering a pre-
booked appointment, may augment the observed effect [41].
Consistent with previous studies, the present trial highlights
that interventions which target nonresponders to take up
screening after a missed appointment can be effective and en-
hanced in a number of ways [41]. The study is the first to show
that sending a reminder to former nonattenders is also effec-
tive and that these individuals should receive such reminders
alongside former nonresponders. Additional reminders, possi-
bly delivered at 24, 36, and even 48 months might improve up-
take even further [27, 28]. As an extension of the present trial,
we are currently investigating whether there is an added bene-
fit to sending a second reminder 24 months after the initial in-
vitation.
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Conclusions
Use of a 12-month reminder in a single center of the English BSS
Programme was effective and improved uptake among former
nonresponders and nonattenders. Inclusion of a theory-based
leaflet added significantly to this strategy, improving uptake
even further. It is important now to test this strategy across
multiple centers and the wider population. If consistent with
the current study, implementing a reminder would increase
population coverage and concomitantly increase the number
of CRCs prevented by the program.
Acknowledgments
We would like to dedicate this article to Professor Jane Wardle
(1950–2015).
We acknowledge funding support from St Mark’s Hospital, Uni-
versity College London (UCL), and Cancer Research UK. R.S.K
has a doctoral studentship funded by St Mark’s Hospital and
UCL; L.M.M. is funded by a CRUK Project Grant (C27064/
A17326) Awarded to C.V.W. We thank St Mark’s Hospital for
supporting this project. In particular, we would like to acknowl-
edge the contributions of Lorraine Gorman and Cherese Ben-
nett, whose advice and support from initial conception to com-
pletion were invaluable to this study.
Competing interests
None
References
[1] Department of Health. NHS Bowel Cancer Screening Programme. Pi-
loting of flexible sigmoidoscopy – Advice to the NHS bidding process.
2012: Available from https://www.gov.uk/government/uploads/
system/uploads/attachment_data/file/215205/dh_132468.pdf Ac-
cessed 29 May 2015
[2] Atkin WS, Edwards R, Kralj-Hans I et al. Once-only flexible sigmoido-
scopy screening in prevention of colorectal cancer: a multicentre
randomised controlled trial. Lancet 2010; 375: 1624–1633
[3] McGregor LM, Bonello B, Kerrison RS et al. Uptake of bowel scope
(flexible sigmoidoscopy) screening in the English National Pro-
gramme: the first 14 months. J Med Screen 2016; 23: 77–82
[4] Geurts S, Massat N, Duffy S. Likely effect of adding flexible sigmoido-
scopy to the English NHS Bowel Cancer Screening Programme: impact
on colorectal cancer cases and deaths. Br J Cancer 2015; 113: 142–
149
[5] Senore C, Ederle A, DePretis G et al. Invitation strategies for colorectal
cancer screening programmes: the impact of an advance notification
letter. Preventive Med 2015; 73: 106–111
[6] Holme Ø, Løberg M, Kalager M et al. Effect of flexible sigmoidoscopy
screening on colorectal cancer incidence and mortality: a randomized
clinical trial. JAMA 2014; 312: 606–615
[7] Vernon SW. Participation in colorectal cancer screening: a review. J
Natl Cancer Institute 1997; 89: 1406–1422
[8] Sutton S, Wardle J, Taylor T et al. Predictors of attendance in the Uni-
ted Kingdom flexible sigmoidoscopy screening trial. J Med Screening
2000; 7: 99–104
[9] Jones RM, Woolf SH, Cunningham TD et al. The relative importance of
patient-reported barriers to colorectal cancer screening. Am J Pre-
ventive Med 2010; 38: 5 , 499–507
[10] Kobayashi LC, Wardle J, von Wagner C. Limited health literacy is a
barrier to colorectal cancer screening in England: evidence from the
English Longitudinal Study of Ageing. Preventive Med 2014; 61: 100–
105
[11] Olynyk JK, Aquilia S, Fletcher DR et al. Flexible sigmoidoscopy screen-
ing for colorectal cancer in average-risk subjects: a community-based
pilot project. Med J Australia 1996; 165: 74–76
[12] Hardcastle J, Farrands P, Balfour T et al. Controlled trial of faecal occult
blood testing in the detection of colorectal cancer. Lancet 1983; 322:
1–4
[13] Tilley BC, Vernon SW, Myers R et al. The Next Step Trial: impact of a
worksite colorectal cancer screening promotion program. Preventive
Med 1999; 28: 276–283
[14] Kelly RB, Shank JC. Adherence to screening flexible sigmoidoscopy in
asymptomatic patients. Med Care 1992; 30: 1029–1042
[15] Nichols S, Koch E, Lallemand R et al. Randomised trial of compliance
with screening for colorectal cancer. BMJ 1986; 293: 107–110
[16] Pye G, Christie M, Chamberlain J et al. A comparison of methods for
increasing compliance within a general practitioner based screening
project for colorectal cancer and the effect on practitioner workload.
J Epidemiol Community Health 1988; 42: 66–71
[17] Wardle J, Williamson S, McCaffery K et al. Increasing attendance at
colorectal cancer screening: testing the efficacy of a mailed, psy-
choeducational intervention in a community sample of older adults.
Health Psychology 2003; 22: 99
[18] Wardle J, von Wagner C, Kralj-Hans I et al. Effects of evidence-based
strategies to reduce the socioeconomic gradient of uptake in the
English NHS Bowel Cancer Screening Programme (ASCEND): four
cluster-randomised controlled trials. Lancet 2016; 387: 751–759
[19] Stone EG, Morton SC, Hulscher ME et al. Interventions that increase
use of adult immunization and cancer screening services: a meta-
analysis. Ann Internal Med 2002; 136: 641–651
[20] Power E, Miles A, von Wagner C et al. Uptake of colorectal cancer
screening: system, provider and individual factors and strategies to
improve participation. Future Oncol 2009; 5: 1371–1388
[21] Senore C, Inadomi J, Segnan N et al. Optimising colorectal cancer
screening acceptance: a review. Gut 2015; 64: 1158–1177
[22] Lewis CL, Brenner AT, Griffith JM et al. The uptake and effect of a
mailed multi-modal colon cancer screening intervention: a pilot con-
trolled trial. Implement Sci 2008; 3: 32
[23] Hewitson P, Ward A, Heneghan C et al. Primary care endorsement
letter and a patient leaflet to improve participation in colorectal can-
cer screening: results of a factorial randomised trial. Br J Cancer 2011;
105: 475–480
[24] Bevan R, Rubin G, Sofianopoulou E et al. Implementing a national
flexible sigmoidoscopy screening program: results of the English ear-
ly pilot. Endoscopy 2015; 47: 225–231
[25] Libby G, Bray J, Champion J et al. Pre-notification increases uptake of
colorectal cancer screening in all demographic groups: a randomized
controlled trial. J Med Screening 2011; 18: 24–29
[26] Allgood PC, Maxwell AJ, Hudson S et al. A randomised trial of the ef-
fect of postal reminders on attendance for breast screening. Br J Can-
cer 2016; 114: 171–176
[27] Lo SH, Halloran S, Snowball J et al. Colorectal cancer screening uptake
over three biennial invitation rounds in the English bowel cancer
screening programme. Gut 2015; 64: 282–291
[28] Steele R, Kostourou I, McClements P et al. Effect of repeated invita-
tions on uptake of colorectal cancer screening using faecal occult
blood testing: analysis of prevalence and incidence screening. BMJ
2010; 341: c5531
42 Kerrison Robert S et al. Improving uptake of… Endoscopy 2017; 49: 35–43
Original article
[29] Pisera M, Kaminski MF, Kraszewska E et al. Reinvitation to screening
colonoscopy: a randomized-controlled trial of reminding letter and
invitation to educational meeting on attendance in nonresponders to
initial invitation screening colonoscopy (REINVITE). Eur J Gastroen-
terol Hepatol 2016; 28: 538–542
[30] Kerrison RS, McGregor LM, Marshall S et al. Use of a 12 months’ self-
referral reminder to facilitate uptake of bowel scope (flexible sigmoi-
doscopy) screening in previous non-responders: a London-based fea-
sibility study. Br J Cancer 2016; 114: 751–758
[31] Power E, Van Jaarsveld CH, McCaffery K et al. Understanding inten-
tions and action in colorectal cancer screening. Ann Behavioral Med
2008; 35: 285–294
[32] Halloran SP. Bowel cancer screening. Surgery (Oxford) 2009; 27:
397–400
[33] Babbie ER. The practice of social research. Belmont, CA: Wadsworth
publishing company; 1998
[34] Kiviniemi MT, Bennett A, Zaiter M et al. Individual‐level factors in
colorectal cancer screening: a review of the literature on the relation
of individual‐level health behavior constructs and screening behavior.
Psychooncology 2011; 20: 1023–1033
[35] Rosenstock IM. The health belief model and preventive health behav-
ior. Health Educ Behav 1974; 2: 354–386
[36] Bandura A. Health promotion by social cognitive means. Health Educ
Behav 2004; 31: 143–164
[37] Ramirez A, Forbes L. Approach to developing information about NHS
cancer screening programmes. King’s Health Partners; 2012
[38] Department for Communities and Local Government. English indices
of deprivation. 2010: Available from https://www.gov.uk/govern-
ment/statistics/english-indices-of-deprivation-2010 Accessed: 10
July 2015
[39] Ferrer RA, Hall KL, Portnoy DB et al. Relationships among health per-
ceptions vary depending on stage of readiness for colorectal cancer
screening. Health Psychology 2011; 30: 525
[40] Wardle J, Miles A, Atkin W. Gender differences in utilization of colo-
rectal cancer screening. J Med Screen 2005; 12: 20–27
[41] von Karsa L, Patnick J, Segnan N et al. European guidelines for quality
assurance in colorectal cancer screening and diagnosis: overview and
introduction to the full supplement publication. Endoscopy 2013; 45:
51
[42] Hudson S, Brazil D, Teh W et al. Effectiveness of timed and non-timed
second appointments in improving uptake in breast cancer screening.
J Med Screen 2016; 23: 160–163
Kerrison Robert S et al. Improving uptake of… Endoscopy 2017; 49: 35–43 43
